dean22029/WTO_Docs huggingface dataset:
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Request by the European Communities for Arbitration under Article 22.6 of the DSU
Date: 7 February 2008
Document codes: WT/DS291/40
Complainant: U.S.
Respondent: EU
Third parties: Argentina, Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay
Dispute stage: Panel
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  AgricultureArt. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Request by the European Communities for Arbitration under Article 22.6 of the DSU

 The following communication, dated 6 February 2008, from the delegation of the
European Communities to the Chairman of the Dis pute Settlement Body, is circulated pursuant to
Article 22.6 of the DSU.

 Regarding the dispute (WT/DS291, WT/DS292, WT/DS293), and pursuant to Article 22.6
of the Understanding on Rules and Procedures Governing the Settlement of Disputes ("DSU"), the
European Communities hereby objects to the requ est made by the United States to the Dispute
Settlement Body ("DSB") for authorization to susp end concessions and other ob ligations with respect
to the European Communities under the covered agreements proposed by the United States in
document

 The level of suspension proposed by the Unite d States is not equivalent to the level of
nullification or impairment within the meaning of Article 22.7 of the DSU. The request does not
follow either the principles or procedures set forth in Article 22.3 of the DSU.

 Accordingly, as required by Article 22.6 of the DSU, the matter shall be referred to
arbitration.

 A copy of this letter has been sent directly to the United States, Argentina and Canada.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Communication from the European Communities
Date: 17 June 2003
Document codes: WT/DS291/13; WT/DS292/10; WT/DS291/1; WT/DS292/1
Complainant: Canada
Respondent: EU
Third parties: Argentina, Australia, Brazil, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. 2.1, 2.2, 2.8, 2.9, 2.11, 2.12, 5.1, 5.2, 5.6, 5.8  Technical Barriers to Trade (TBT)Art. I:1, III:4, X:1, XI:1  GATT 1994Art. 4.2  Agriculture

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
Communication from the European Communities
The following communication, dated 11 June 2003, from the Permanent Delegation of the
European Commission to the Permanent Mission of Argentina and to the Chairman of the Dispute
Settlement Body is circulated at the request of the European Communities.
I would like to refer to your letter dated 30 May 2003 expressing the desire of Argentina to be
joined in the consultations requested by the United States and Canada on the approval and marketing
of genetically-modified organisms (documents and ).
The European Communities accepts the request of Argentina. The consultations in the
disputes WT/DS291 and WT/DS293 will be held jointly, as agreed. I will inform you as soon as
possible of the date and venue of the consultations between the European Communities and Canada.
A copy of this letter is being sent to the Chairman of the Dispute Settlement Body for
circulation to Members.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Communication from the European Communities
Date: 17 June 2003
Document codes: WT/DS291/12; WT/DS292/9; WT/DS293/9
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
Communication from the European Communities
The following communication, dated 11 June 2003, from the Permanent Delegation of the
European Commission to the Permanent Mission of Australia and to the Chairman of the Dispute
Settlement Body is circulated at the request of the European Communities.
Thank you for your letters of 28 May 2003 in which you request to be joined in the
consultations in the disputes WT/DS291, WT/DS292 and WT/DS293.
Article 4.11 of the Understanding on Rules and Procedures Governing the Settlement of
Disputes provides that "[w]henever a Member other than the consulting Members consider that it has
a substantial trade interest in consultations being held pursuant to [the relevant provisions of the
WTO Agreement], such Member may notify the consulting Members and the DSB […] of its desire to
be joined in the consultations. Such Member shall be joined in the consultations, provided that the
Member to which the request for consultations was addressed agrees that the claim of substantial
interest is well-founded […]".
The European Communities is not aware of any Australian agricultural imports or exports
being affected by any measures adopted by the European Communities with regard to
genetically-modified organisms. Nevertheless, the European Communities agrees that Australia has a
substantial interest in the consultations. Indeed, according to the information available to the
European Communities, several Australian States (notably Tasmania and Western Australia) have
enacted different types of 'moratoria' on commercially-grown GM crops, and others are considering
legislation with the same objective. The allegations of the consulting Members may therefore have
important implications for Australia.
For these reasons, the European Communities can accept Australia's participation in the
consultations. We hope that the consultations will contribute to a better understanding of the situation
of biotechnology products in the European Communities and other WTO Members.
I will inform you as soon as possible of the date and venue of the consultations.
A copy of this letter is being sent to the Chairman of the Dispute Settlement Body for
circulation to Members.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Communication from the European Communities
Date: 17 June 2003
Document codes: WT/DS291/14; WT/DS292/11; WT/DS293/10
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
Communication from the European Communities
The following communication, dated 11 June 2003, from the Permanent Delegation of the
European Commission to the Permanent Mission of Brazil and to the Chairman of the Dispute
Settlement Body is circulated at the request of the European Communities.
Thank you for your letter of 28 May 2003 in which you request to be joined in the
consultations in the disputes WT/DS291, WT/DS292 and WT/DS293 concerning the approval and
marketing of genetically-modified organisms.
Article 4.11 of the Understanding on Rules and Procedures Governing the Settlement of
Disputes provides that "[w]henever a Member other than the consulting Members consider that it has
a substantial trade interest in consultations being held pursuant to [the relevant provisions of the
WTO Agreement], such Member may notify the consulting Members and the DSB […] of its desire to
be joined in the consultations. Such Member shall be joined in the consultations, provided that the
Member to which the request for consultations was addressed agrees that the claim of substantial
interest is well-founded […]".
The European Communities understands Brazil's interest in the consultations. Indeed, the
allegations of Argentina, Canada and the United States may be of relevance to WTO Members that
have adopted or are intending to adopt legislation on genetically-modified organisms, in accordance
with their own legitimate values and objectives as well as specific international rules on
biotechnology products. Besides, the European Co mmunities recognizes your concern about the
protection of biodiversity, among other important issues related to biotechnology products.
For these reasons, the European Communities can accept Brazil's participation in the
consultations. I will inform you as soon as possible of the date and venue of the meetings.
We hope that the consultations will contribute to a better understanding of the situation of
biotechnology products in the European Communities and other WTO Members.
A copy of this letter is being sent to the Chairman of the Dispute Settlement Body for
circulation to Members.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Communication from the European Communities
Date: 17 June 2003
Document codes: WT/DS291/15; WT/DS293/11; WT/DS291/1; WT/DS293/1
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
Communication from the European Communities
The following communication, dated 11 June 2003, from the Permanent Delegation of the
European Commission to the Permanent Mission of Canada and to the Chairman of the Dispute
Settlement Body is circulated at the request of the European Communities.
I would like to refer to your letters dated 30 May 2003 expressing the desire of Canada to be
joined in the consultations requested by the United States and Argentina on the approval and
marketing of genetically-modified organisms (documents and ).
The European Communities accepts the request of Canada. I will inform you as soon as
possible of the date and venue of the consultations.
A copy of this letter is being sent to the Chairman of the Dispute Settlement Body, for
circulation to Members.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Communication from the European Communities
Date: 17 June 2003
Document codes: WT/DS291/18; WT/DS292/12; WT/DS293/12
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
Communication from the European Communities
The following communication, dated 11 June 2003, from the Permanent Delegation of the
European Commission to the Permanent Mission of India and to the Chairman of the Dispute
Settlement Body is circulated at the request of the European Communities.
Thank you for your letters of respectively 28 May 2003 and 4 June 2003 in which you request
to be joined in the consultations in the di sputes WT/DS291, WT/DS292 and WT/DS293 concerning
the approval and marketing of genetically-modified products.
Article 4.11 of the Understanding on Rules and Procedures Governing the Settlement of
Disputes provides that "[w]henever a Member other than the consulting Members consider that it has
a substantial trade interest in consultations being held pursuant to [the relevant provisions of the
WTO Agreement], such Member may notify the consulting Members and the DSB […] of its desire to
be joined in the consultations. Such Member shall be joined in the consultations, provided that the
Member to which the request for consultations was addressed agrees that the claim of substantial
interest is well-founded […]".
The European Communities understands India's interest in the consultations. Indeed, the
allegations of Argentina, Canada and the United States may be of relevance to WTO Members that
have adopted or are intending to adopt legislation on genetically-modified organisms, in accordance
with their own legitimate values and objectives as well as specific international rules on
biotechnology products.
For these reasons, the European Communities can accept India's participation in the
consultations, without prejudice to the question whether India has a substantial trade interest in them.
I will inform you as soon as possible of the date and venue of the meetings.
However, I can already inform you that the European Communities, Argentina and the United
States have agreed to hold joint consultations (DS291 and DS293). The consultations with Canada
(DS292) will be held separately.
We hope that the consultations will contribute to a better understanding of the situation of
biotechnology products in the European Communities and other WTO Members.
A copy of this letter is being sent to the Chairman of the Dispute Settlement Body for
circulation to Members.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Communication from the European Communities
Date: 17 June 2003
Document codes: WT/DS291/19; WT/DS292/13; WT/DS293/13
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
Communication from the European Communities
The following communication, dated 11 June 2003, from the Permanent Delegation of the
European Commission to the Permanent Mission of Mexico and to the Chairman of the Dispute
Settlement Body is circulated at the request of the European Communities.
Thank you for your letters of 27 May 2003 in which you request to be joined in the
consultations in the disputes WT/DS291, WT/DS292 and WT/DS293.
Article 4.11 of the Understanding on Rules and Procedures Governing the Settlement of
Disputes provides that "[w]henever a Member other than the consulting Members consider that it has
a substantial trade interest in consultations being held pursuant to [the relevant provisions of the
WTO Agreement], such Member may notify the consulting Members and the DSB […] of its desire to
be joined in the consultations. Such Member shall be joined in the consultations, provided that the
Member to which the request for consultations was addressed agrees that the claim of substantial
interest is well-founded […]".
The European Communities is not aware of any Mexican exports being affected by any
measure of the European Communities concerning genetically-modified organisms. Nevertheless, the
European Communities can agree to Mexico's interest in the consultations. Indeed, according to the
information available to the European Communities, Mexico has suspended authorizations for large-
scale commercial growing of genetically-modified corn within its territory, due to ongoing
discussions on their potential impact on wild relatives and traditional crops. The allegations of
Argentina, Canada and the United States may therefore have important implications for Mexico.
For these reasons, the European Communities accepts Mexico's participation in the
consultations. I will inform you as soon as possible of the date and venue of the meetings.
We hope that the consultations will contribute to a better understanding of the situation of
biotechnology products in the European Communities and other WTO Members.
A copy of this letter is being sent to the Chairman of the Dispute Settlement Body for
circulation to Members.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Communication from the European Communities
Date: 17 June 2003
Document codes: WT/DS291/20; WT/DS292/14; WT/DS293/14
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS
Communication from the European Communities
The following communication, dated 11 June 2003, from the Permanent Delegation of the
European Commission to the Permanent Mission of New Zealand and to the Chairman of the Dispute
Settlement Body is circulated at the request of the European Communities.
Thank you for your letter of 28 May 2003 in which you request to be joined in the
consultations in the disputes WT/DS291, WT/DS292 and WT/DS293.
Article 4.11 of the Understanding on Rules and Procedures Governing the Settlement of
Disputes provides that "[w]henever a Member other than the consulting Members consider that it has
a substantial trade interest in consultations being held pursuant to [the relevant provisions of the
WTO Agreement], such Member may notify the consulting Members and the DSB […] of its desire to
be joined in the consultations. Such Member shall be joined in the consultations, provided that the
Member to which the request for consultations was addressed agrees that the claim of substantial
interest is well-founded […]".
The European Communities is not aware of any exports from New Zealand being affected by
any measure of the European Communities concerning genetically-modified organisms. This is
hardly surprising given the fact that, according to the information available to the European
Communities, no living modified organisms can at present be grown or introduced into New Zealand
as a result of the Hazardous Substances and New Organisms Act of 1996.
Nevertheless, the European Communities can agree to New Zealand's claim of substantial
interest in the consultations, as New Zealand has enacted a moratorium on GMOs and the allegations
of Argentina, Canada and the United States may ha ve important implications in that regard. I will
inform you as soon as possible of the date and venue of the meetings.
We hope that the consultations will contribute to a better understanding of the situation of
biotechnology products in the European Communities and other WTO Members.
A copy of this letter is being sent to the Chairman of the Dispute Settlement Body for
circulation to Members.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Communication from the Chairman of the Panel
Date: 20 August 2004
Document codes: WT/DS291/26; WT/DS292/20; WT/DS293/20; WT/DS291/25; WT/DS292/19; WT/DS293/19
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Communication from the Chairman of the Panel

 The following communication, dated 18 Augus t 2004, addressed to the Dispute Settlement
Body (DSB), is circulated in accordance with Article 12.9 of the Dispute Settlement Understanding
(DSU).

 The Panel in European Communities – Measures Affec ting the Approval and Marketing of
Biotech Products (WT/DS291, WT/DS292 and WT/DS293) indicated in its communication to the
DSB of 12 July 2004 (, , ) that it would provide at a later
date an estimate of the period within which it will is sue its report. The Panel is now in a position to
do so. The Panel estimates that it will issue its final report to the parties by the end of March 2005.
This delay is due to the parties' common request for additional time to prepare their rebuttals as well as
the Panel's decision to seek scient ific and technica l expert advice pursuant to Article 11 of the
Agreement on Sanitary and Phytosanitary Measures and Article 13 of the DSU.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Communication from the Chairman of the Panel
Date: 2 November 2004
Document codes: WT/DS291/27; WT/DS292/21; WT/DS293/21; WT/DS291/26; WT/DS292/20; WT/DS293/20
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Communication from the Chairman of the Panel

 The following communication, dated 2 Novemb er 2004, addressed to the Dispute Settlement
Body (DSB), is circulated in accordance with Article 12.9 of the Dispute Settlement Understanding
(DSU).

 The Panel in European Communities – Measures Affec ting the Approval and Marketing of
Biotech Products (WT/DS291, WT/DS292 and WT/DS293) indicated in its communication to the
DSB of 20 August 2004 (, , ) that it expected to issue its
final report to the parties by the end of March 2005. However, as a result of the time taken to identify
and select experts and, more importa ntly, in view of a joint request by all four parties that they be
granted additional time to prepare their further submissions to the Panel, it will not be possible for the
Panel to issue its final report to the parties by the end of March 2005. The Panel estimates that it will
issue its final report to the parties by the end of June 2005.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Communication from the Chairman of the Panel
Date: 15 June 2005
Document codes: WT/DS291/28; WT/DS292/22; WT/DS293/22; WT/DS291/27; WT/DS292/21; WT/DS293/21
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Communication from the Chairman of the Panel

 The following communication, dated 13 June 2005, addressed to the Dispute Settlement Body
(DSB), is circulated in accordance with Article 12.9 of the Dispute Settlement Understanding (DSU).

 The Panel in European Communities – Measures Affec ting the Approval and Marketing of
Biotech Products (WT/DS291, WT/DS292 and WT/DS293) indicated in its communication to the
DSB of 2 November 2004 (, , ) that it expected to issue its
final report to the parties by the end of June 2005. However, it will not be possible for the Panel to issue
its final report to the parties by that time.

The delay is due to a number of reasons. Fi rst, before and after the second substantive
meeting, the Panel has had to deal with several im portant new issues raised by the parties, which has
delayed the inception of the Panel's work on its findings . Second, the case is particularly intricate in
view of the large number of product applications, and the arguments by the parties entail precise and
detailed examination of the info rmation submitted to the Panel. Third, the experts process has
produced a vast amount of material which also needs to be reviewed. Human resource limitations and
panel members’ availability are additional constraints to an expedient termination of our work.

The Panel estimates that it will issue its final report to the parties by the end of October 2005.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Communication from the Chairman of the Panel
Date: 15 August 2005
Document codes: WT/DS291/29; WT/DS292/23; WT/DS293/23; WT/DS291/28; WT/DS292/22
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Communication from the Chairman of the Panel

 The following communication, dated 11 Augus t 2005, addressed to the Dispute Settlement
Body (DSB), is circulated in accordance with Article 12.9 of the Dispute Settlement Understanding
(DSU).

The Panel in European Communities – Measures Affec ting the Approval and Marketing of
Biotech Products (WT/DS291, WT/DS292 and WT/DS293) indicated in its communication to the
DSB of 13 June 2005 (, , WT/DS2 93/22) that it expected to issue its final
report to the parties by the end of October 2005. However, it will not be possible for the Panel to do so
by that time. Due to the need to address an unusually large number of issues, the Panel requires
additional time to prepare and finalise its report.

The Panel estimates that it will issue its final report to the parties by the end of December 2005.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Communication from the Chairman of the Panel
Date: 21 December 2005
Document codes: WT/DS291/30; WT/DS292/24; WT/DS293/24; WT/DS291/29; WT/DS292/23; WT/DS293/23
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Communication from the Chairman of the Panel

 The following communication, dated 21 Dece mber 2005, addressed to the Dispute Settlement
Body (DSB), is circulated in accordance with Article 12.9 of the Dispute Settlement Understanding
(DSU).

The Panel in European Communities – Measures Affec ting the Approval and Marketing of
Biotech Products (WT/DS291, WT/DS292 and WT/DS293) indicated in its communication to the
DSB of 11 August 2005 (, , ) that it expected to issue its
final report to the parties by the end of December 2005. However, it will not be possible for the Panel to
do so. Due to the large number of issues to be addressed, the Panel requires additional time to prepare
and finalize its report. Also, since much more time and effort was required for this case than
originally planned for, some of the Secretariat staff is no longer available to the Panel.

The Panel estimates that it will issue its final report to the parties by the end of March 2006.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Communication from the Chairman of the Panel
Date: 31 March 2006
Document codes: WT/DS291/31; WT/DS292/25; WT/DS293/25; WT/DS291/30; WT/DS292/24; WT/DS293/24
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Communication from the Chairman of the Panel

 The following communication, dated 30 Marc h 2006, addressed to the Dispute Settlement
Body (DSB), is circulated in accordance with Article 12.9 of the Dispute Settlement Understanding
(DSU).

 The Panel in European Communities – Measures Affec ting the Approval and Marketing of
Biotech Products (WT/DS291, WT/DS292 and WT/DS293) indicated in its communication to the
DSB of 21 December 2005 (, , ) that it expected to issue
its final reports to the parties by the end of March 2006. However, it will not be possible for the Panel
to do so. The Panel has yet to receive, in the second half of April, further comments from the Parties
on its interim reports. The Panel estimates that it w ill issue its final reports to the parties by mid-May
2006. At that point, the Secretariat needs to comple te the translation of the reports before they are
circulated to Members. In view of the unprecedente d length and complexity of the Panel reports, it is
not possible to provide an exact date of circulation of the reports to Members. It is estimated that the
Panel reports will be circulated to Members no later than the end of September 2006.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Notification of an Agreement with respect to Article 21.3(c) of the DSU
Date: 22 January 2007
Document codes: WT/DS291/34; WT/DS292/28; WT/DS293/28
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Notification of an Agreement with respect to Article 21.3(c) of the DSU

 The following communication, dated 19 January 2007, from the delegations of the European
Communities, Argentina, Canada and the United St ates to the Chairman of the Dispute Settlement
Body, is circulated at the request of those delegations.

 At its meeting on 21 November 2006, the Di spute Settlement Body (DSB) adopted the reports
of the Panel in the disputes (WT/DS291, 292, 293). At the meeting of the DSB held on 19 December 2006,
the European Communities (EC) notified the DS B that the EC intends to implement the
recommendations and rulings of the DSB in these dis putes, and stated that it would need a reasonable
period of time for implementation.

 Article 21.3(c) of the DSU provides that, in the absence of an agreement between the parties
on a period of time, the reasonable period of time shall be determined "t hrough binding arbitration
within 90 days after the date of adoption of the recommendations and rulings". In order to allow
sufficient time for the parties to discuss a mutually agreed period, the EC, Argentina, Canada and the
United States (i) have agreed that any arbitra tions under Article 21.3(c) of the DSU shall be
completed no later than 60 days after the date of the appointment of an arbitrator, unless the arbitrator,
following consultation with the parties, considers th at additional time is required; and (ii) hereby
confirm that any awards of the arbitrator (including awards not made within 90 days after the date of
adoption of the recommendations and rulings) shall be deemed to be awards of the arbitrator for the
purposes of Article 21.3(c) of the DSU in determining the reasonable period of time for the EC to
implement the recommendations and rulings of the DSB.
EUROPEAN COMMUNITIES - MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Status Report by the European Communities
Date: 11 January 2008
Document codes: WT/DS291/37; WT/DS292/31; WT/DS293/31
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES - MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Status Report by the European Communities

 The following communication, dated 10 January 2008, from the delegation of the European
Communities to the Chairman of the Dispute Settleme nt Body, is circulated pursuant to Article 21.6
of the DSU.

Status Report Regarding Implementation of the

DSB Recommendations and Rulings in the Dispute
 (WT/DS291, WT/DS292, WT/DS293)

 Under Article 21.6 of the Understanding on Rules and Procedures Governing the Settlement
of Disputes ("DSU"), the European Communities has to submit a status report on this case by
10 January 2008.

 On 21 November 2006, the Dispute Settlement Body ("DSB") adopted the Panel report in
European Communities - Measures Affecting th e Approval and Marketing of Biotech Products . At
the DSB meeting of 19 December 2006, the Eur opean Communities confirmed its intention to
implement the recommendations and rulings of the DS B in this dispute, and stated that it would
require a "reasonable period of time" in which to do so, according to Article 21.3 of the DSU.

 By communication of 21 June 2007, the Europ ean Communities and the three complainants
notified to Chairman of the DSB that, pursuant to Article 21.3(b) of the DSU, they had mutually
agreed on a reasonable period of time of 12 months from the date of adoption of the Panel Report for
the European Communities to implement the recommendations and rulings of the DSB in this dispute,
which would expire on 21 November 2007.

 By communications of 21 November 2007 (, and
), the EC and the three complainants no tified to the Chairman of the DSB that they had
mutually agreed to extend the reasonable period of time for implementation originally established
until 11 January 2008.

 The European Communities and the three compla inants are currently engaged in constructive
discussions with the goal of resolving this dispute and related issues.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Status Report by the European Communities Addendum
Date: 8 February 2008
Document codes: WT/DS291/37/Add.1; WT/DS292/31/Add.1; WT/DS293/31/Add.1
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Status Report by the European Communities

Addendum

 The following communication, dated 7 February 2008, from the delegation of the European
Communities to the Chairman of the Dispute Settleme nt Body, is circulated pursuant to Article 21.6
of the DSU.

Status Report Regarding Implementation of the

DSB Recommendations and Rulings in the Dispute
European Communities- Measures Affecting the Approval and Marketing of
Biotech Products (WT/DS291, WT/DS292, WT/DS293)

 Since its last status report, the European Communities and the three complainants have
continued to be engaged in constructive discussions with the goal of resolving this dispute and related
issues.

 Further extensions of the reasonable period of time beyond 11 January 2008 have been agreed
under Article 21.3(b) of the Understanding on Rules and Procedures Governing the Settlement of
Disputes with Argentina and Canada.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Status Report by the European Communities Addendum
Date: 4 March 2008
Document codes: WT/DS291/37/Add.2; WT/DS292/31/Add.2; WT/DS293/31/Add.2
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Status Report by the European Communities

Addendum

 The following communication, dated 3 March 2008, from the delegation of the European
Communities to the Chairman of the Dispute Settleme nt Body, is circulated pursuant to Article 21.6
of the DSU.

Status Report Regarding Implementation of the

DSB Recommendations and Rulings in the Dispute

(WT/DS291, WT/DS292, WT/DS293)

 Since its last status report, the European Communities and the three complainants have
continued to be engaged in constructive discussions with the goal of resolving this dispute and related
issues.

 Further extensions of the reasonable period of time beyond 11 January 2008 were agreed
under Article 21.3(b) of the Understanding on Rules and Procedures Governing the Settlement of
Disputes with Argentina and Canada. On 15 February 2008, the US and the EC requested the
suspension of arbitration proceedings under Article 22.6 DSU in order to allow the dialogue to
continue.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Status Report by the European Communities Addendum
Date: 8 April 2008
Document codes: WT/DS291/37/Add.3; WT/DS292/31/Add.3; WT/DS293/31/Add.3
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Status Report by the European Communities

Addendum

 The following communication, dated 7 April 2008, from the delegation of the European
Communities to the Chairman of the Dispute Settleme nt Body, is circulated pursuant to Article 21.6
of the DSU.

Status Report Regarding Implementation of the

DSB Recommendations and Rulings in the Dispute

(WT/DS291, WT/DS292, WT/DS293)

 Since its last status report, the European Communities and the three complainants have
continued to be engaged in constructive discussions with the goal of resolving this dispute and related
issues.

 In order to allow this dialogue to continue, Argentina and Canada have agreed to further
extend the reasonable period of time for implementa tion until 11 and 30 June 2008 respectively. As
requested by the US and the EC, the arbitrati on proceedings under Article 22.6 DSU on the US
retaliation request were suspended as of 18 February 2008.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Status Report by the European Communities Addendum
Date: 9 May 2008
Document codes: WT/DS291/37/Add.4; WT/DS292/31/Add.4; WT/DS293/31/Add.4
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Status Report by the European Communities

Addendum

 The following communication, dated 8 May 2008, from the delegation of the European
Communities to the Chairman of the Dispute Settleme nt Body, is circulated pursuant to Article 21.6
of the DSU.

Status Report Regarding Implementation of the

DSB Recommendations and Rulings in the Dispute

(WT/DS291, WT/DS292, WT/DS293)

 Since its last status report, the European Communities and the three complainants have
continued to be engaged in constructive discussions with the goal of resolving this dispute and related
issues.

 In order to allow this dialogue to continue , Argentina and Canada had agreed to further
extend the reasonable period of time for implementa tion until 11 and 30 June 2008 respectively. As
requested by the US and the EC, the arbitrati on proceedings under Article 22.6 DSU on the US
retaliation request were suspended as of 18 February 2008.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Status Report by the European Communities Addendum
Date: 13 June 2008
Document codes: WT/DS291/37/Add.5; WT/DS292/31/Add.5; WT/DS293/31/Add.5
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Status Report by the European Communities

Addendum

 The following communication, dated 12 June 2008, from the delegation of the European
Communities to the Chairman of the Dispute Settleme nt Body, is circulated pursuant to Article 21.6
of the DSU.

Status Report Regarding Implementation of the

DSB Recommendations and Rulings in the Dispute

(WT/DS291, WT/DS292, WT/DS293)

 Since the last status report by the Europ ean Communities, the Austrian measures on import
and processing of GMO maize MON810 and T-25, which were found WTO incompatible by the
panel, have been formally removed by the Austrian authorities.

The European Communities and the three compla inants have continue d to be engaged in
constructive discussions with the goal of resolving this dispute and related issues.

 In order to allow this dialogue to continue, Argentina has agreed to further extend the
reasonable period of time for implementation of the WTO panel report until 12 August 2008. Further
discussions between the United States and the Europ ean Communities are scheduled to take place on
18 and 19 June 2008.
EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL AND MARKETING OF BIOTECH PRODUCTS
Document: Status Report by the European Communities Addendum
Date: 21 July 2008
Document codes: WT/DS291/37/Add.6; WT/DS292/31/Add.6; WT/DS293/31/Add.6
Complainant: Argentina
Respondent: EU
Third parties: Australia, Brazil, Canada, Chile, China, Taiwan, Colombia, El Salvador, Honduras, Mexico, New Zealand, Norway, Paraguay, Peru, Thailand, Uruguay, U.S.
Dispute stage: Mutually Agreed Solution
Agreements cited: Art. 2.2, 2.3, 5.1, 5.2, 5.5, 5.6, 7, 8, 10.1, Annex B, Annex C  Sanitary and Phytosanitary Measures (SPS)Art. III:4, X:1, X:3(a), XI:1  GATT 1994Art. 2.1, 2.2, 2.8, 2.9, 2.11, 5.1, 5.2, 5.6, 5.8, 12  Technical Barriers to Trade (TBT)Art. 4.2  AgricultureArt. I:1  GATT 1994

EUROPEAN COMMUNITIES – MEASURES AFFECTING THE APPROVAL
AND MARKETING OF BIOTECH PRODUCTS

Status Report by the European Communities

Addendum

 The following communication, dated 18 July 2008, from the delegation of the European
Communities to the Chairman of the Dispute Settleme nt Body, is circulated pursuant to Article 21.6
of the DSU.

Status Report Regarding Implementation of the

DSB Recommendations and Rulings in the Dispute

(WT/DS291, WT/DS292, WT/DS293)

 The European Communities and the three compla inants have continue d to be engaged in
constructive discussions with the goal of resolving this dispute and related issues.

 In order to allow this dialogue to continue, Ca nada has agreed to further extend the reasonable
period of time for implementation of the WTO panel report until 31 July 2008 ().